Core Viewpoint - Shanghai Xuantai Pharmaceutical Technology Co., Ltd. has announced a differentiated cash dividend distribution plan for the fiscal year 2024, with a cash dividend of 0.037 CNY per share [1][2]. Summary by Sections Dividend Distribution Plan - The profit distribution plan was approved at the annual general meeting on May 29, 2025 [1]. - The total number of shares eligible for the cash dividend is 449,003,891 shares after deducting 4,336,109 shares held in the company's repurchase account [2]. - The cash dividend distribution is based on the total number of shares minus the repurchased shares, with a distribution of 0.037 CNY for every 10 shares held [1][2]. Calculation of Ex-Dividend Price - The ex-dividend reference price is calculated using the formula: (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [2]. - Since there is no change in circulating shares, the circulating shares change ratio is 0, and the cash dividend per share remains 0.037 CNY [2]. Relevant Dates - The key dates for the dividend distribution include the record date, ex-dividend date, and cash dividend payment date [3]. Implementation of Distribution - The cash dividends will be distributed through China Securities Depository and Clearing Corporation Limited, Shanghai Branch, to shareholders registered by the record date [3]. - Shares held in the company's repurchase account will not participate in the profit distribution [3]. Tax Implications - For individual shareholders holding shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.037 CNY per share [4]. - For shares held for less than one year, the tax will be calculated upon transfer of the shares, with a potential tax burden of 20% for shares held for one month or less [4][5]. - Non-resident enterprises will be subject to a 10% withholding tax, resulting in a net cash dividend of 0.0333 CNY per share [5][6]. Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the board office at 021-68819009-657 or via email at info@sinotph.com [6].
宣泰医药: 2024年年度权益分派实施公告